Synlogic, Inc. (SYBX)
OTCMKTS · Delayed Price · Currency is USD
0.5650
-0.0062 (-1.09%)
At close: Jan 23, 2026
Synlogic Market Cap
Synlogic has a market cap or net worth of $6.61 million as of January 23, 2026. Its market cap has decreased by -60.20% in one year.
Market Cap
6.61M
Enterprise Value
-8.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.57
Market Cap Chart
Since August 28, 2017, Synlogic's market cap has decreased from 196.53M to 6.61M, a decrease of -96.64%. That is a compound annual growth rate of -33.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 6.61M | -49.55% |
| Dec 31, 2025 | 13.10M | -19.98% |
| Dec 31, 2024 | 16.37M | -53.72% |
| Dec 29, 2023 | 35.38M | -33.99% |
| Dec 30, 2022 | 53.60M | -68.23% |
| Dec 31, 2021 | 168.70M | 124.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rize Oncology | 12.12M |
| AccuStem Sciences | 9.96M |
| Biomind Labs | 8.84M |
| Zenith Capital | 7.99M |
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 6.54M |
| Brainstorm Cell Therapeutics | 6.51M |
| Bioxytran | 6.46M |